Richard Kim's most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 147,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Pharmaceuticals plc... | Richard Kim | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 147,000 | 147,000 | - | - | Stock Option (Right to Buy) | |
| Intercept Pharmaceuticals Inc | Richard Kim | President US Comm & Strat Mktg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. | 01 Oct 2020 | 223 | 20,828 (0%) | 0% | 42.1 | 9,384 | Common Stock |